2015 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 8B
| State/Territory | Active | Inactive | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Connecticut | 380 | 39.3 | 3.8 | (31.9 – 46.7) | 123 | 23.5 | 5.5 | (12.7 – 34.3) |
| Florida | 238 | 32.8 | 4.8 | (23.4 – 42.2) | 88 | 31.8 | 7.5 | (17.1 – 46.5) |
| Georgia | 179 | 31.9 | 5.6 | (20.9 – 42.9) | 66 | N/A | N/A | (N/A – N/A) |
| Hawaii | 192 | 34.4 | 5.2 | (24.2 – 44.6) | 65 | N/A | N/A | (N/A – N/A) |
| Indiana | 222 | 42.8 | 6.2 | (30.6 – 55.0) | 77 | 33.0 | 8.3 | (16.7 – 49.3) |
| Iowa | 193 | 38.6 | 5.1 | (28.6 – 48.6) | 64 | 27.4 | 7.7 | (12.3 – 42.5) |
| Kansas | 614 | 38.1 | 2.6 | (33.0 – 43.2) | 208 | 21.0 | 3.4 | (14.3 – 27.7) |
| Maine | 275 | 40.0 | 4.5 | (31.2 – 48.8) | 91 | 25.4 | 6.8 | (12.1 – 38.7) |
| Massachusetts | 278 | 37.9 | 4.6 | (28.9 – 46.9) | 70 | 32.2 | 6.9 | (18.7 – 45.7) |
| Michigan | 441 | 47.7 | 3.2 | (41.4 – 54.0) | 95 | 18.3 | 5.2 | (8.1 – 28.5) |
| Minnesota | 630 | 29.7 | 2.4 | (25.0 – 34.4) | 193 | 19.4 | 3.6 | (12.3 – 26.5) |
| Mississippi | 174 | 33.6 | 6.5 | (20.9 – 46.3) | 41 | N/A | N/A | (N/A – N/A) |
| Missouri | 204 | 35.2 | 5.7 | (24.0 – 46.4) | 50 | N/A | N/A | (N/A – N/A) |
| Montana | 146 | 44.0 | 6.6 | (31.1 – 56.9) | 48 | N/A | N/A | (N/A – N/A) |
| Nebraska | 507 | 32.2 | 3.6 | (25.1 – 39.3) | 171 | 15.2 | 3.5 | (8.3 – 22.1) |
| Nevada | 113 | 21.8 | 5.4 | (11.2 – 32.4) | 31 | N/A | N/A | (N/A – N/A) |
| New Hampshire | 214 | 33.8 | 5.2 | (23.6 – 44.0) | 62 | N/A | N/A | (N/A – N/A) |
| New Jersey | 445 | 22.9 | 3.1 | (16.8 – 29.0) | 148 | N/A | N/A | (N/A – N/A) |
| New Mexico | 278 | 29.8 | 4.4 | (21.2 – 38.4) | 76 | N/A | N/A | (N/A – N/A) |
| New York | 241 | 38.6 | 4.6 | (29.6 – 47.6) | 70 | 31.6 | 7.7 | (16.5 – 46.7) |
| Ohio | 426 | 30.3 | 4.4 | (21.7 – 38.9) | 89 | N/A | N/A | (N/A – N/A) |
| Oregon | 221 | 33.7 | 4.5 | (24.9 – 42.5) | 60 | 26.6 | 7.8 | (11.3 – 41.9) |
| Pennsylvania | 226 | 39.0 | 5.0 | (29.2 – 48.8) | 59 | N/A | N/A | (N/A – N/A) |
| Rhode Island | 217 | 31.2 | 5.2 | (21.0 – 41.4) | 45 | N/A | N/A | (N/A – N/A) |
| Texas | 425 | 40.4 | 4.8 | (31.0 – 49.8) | 126 | 29.0 | 7.0 | (15.3 – 42.7) |
| Utah | 403 | 27.0 | 2.8 | (21.5 – 32.5) | 126 | 16.3 | 4.8 | (6.9 – 25.7) |
| Vermont | 255 | 38.4 | 4.2 | (30.2 – 46.6) | 95 | 16.8 | 4.7 | (7.6 – 26.0) |
| Wisconsin | 290 | 33.3 | 4.3 | (24.9 – 41.7) | 56 | N/A | N/A | (N/A – N/A) |
| Puerto Rico | 325 | 48.8 | 3.5 | (41.9 – 55.7) | 98 | 40.8 | 7.5 | (26.1 – 55.5) |
| 29 states / area | 8,752 | 36.4 | 1.2 | (34.0 – 38.8) | 2,591 | 26.5 | 2.2 | (22.2 – 30.8) |
| Median | 34.4 | 26.0 | ||||||
| Range | 21.8-48.8 | 15.2-40.8 | ||||||
1 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
2 Reported none of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
3 Aged ≥ 18 years
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30
Page last reviewed: June 11, 2018